← Back
$ANIK All transactions

Anika Therapeutics, Inc.

M

$ Value

$0

Shares

12,840

Price

$0

Filed

Jun 5

Insider

Name

Griffin Stephen D.

Title

EVP, CFO & COO

CIK

0001831125

Roles

Officer

Transaction Details

Transaction Date

2025-06-03

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,640

Footnotes

Reflects the first vesting installment of RSUs granted on June 3, 2024. | Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan. | Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025. | Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations. | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.

Filing Info

Accession No.

0001171843-25-003729

Form Type

4

Issuer CIK

0000898437

Griffin Stephen D.'s History

Date Ticker Type Value
2025-06-03 ANIK M $0
2025-06-03 ANIK F $44K
2025-06-03 ANIK M $0

Other Insiders at ANIK (90d)

No other insider activity at this issuer in the last 90 days.